Editor's Note The US Department of Health and Human Services (HHS) and Pfizer have announced an agreement to extend patient access to the COVID-19 drug Paxlovid, Healthcare Purchasing News October 16 reports. According to the article, Pfizer is readying the drug for more availability in the commercial market in November…

Read More

Editor's Note High-performance intensive care units (ICUs) may have better patient outcomes during health crises such as the COVID-19 pandemic, according to new findings published by the journal CHEST. The study, titled "The association between pre-pandemic ICU performance and mortality variation in COVID-19: A multicenter cohort study of 35,619 critically…

Read More

The COVID-19 pandemic has amplified existing personnel shortages in hospitals and ambulatory surgery centers (ASC), which are anticipated to persist. Before the pandemic, nursing supply and demand were already affected negatively by several factors, including approximately 70,000 Baby Boomer RNs retiring per year. As the remaining Baby Boomer RNs retire over…

Read More

Editor's Note An October 2023 investigative study published by JAMA Network looked at physician burnout among US physicians over the past 5 years and found that burnout is increasing, JAMA October 6 reports. According to the study, burnout is a threat to the US healthcare system and physicians' ability to…

Read More

Editor's Note Due to staffing shortages, thousands of qualified applicants were turned away from nursing schools last year, despite the nationwide shortage of nurses, CNN Business October 5 reports. According to the American Association of Colleges of Nursing, nearly 78,200 qualified applications were denied by nursing schools in 2022. Nearly 66,300…

Read More

Editor's Note A new vaccine for respiratory syncytial virus (RSV) has been found to be effective against a range of variants, according to an August 2023 Science Translational Medicine research article titled, "The RSVPreF3-AS01 vaccine elicits broad neutralization of contemporary and antigenically distant respiratory syncytial virus strains." This research was…

Read More

Editor's Note This new study from the Cleveland Clinic found that use of COVID-19 antiviral drugs Paxlovid (nirmatrelvir) and Lagevrio (molnupiravir) reduces risk of hospitalization and death in high-risk patients with mild disease, even against Omicron subvariants. The findings were published in JAMA Network on September 21. The study included…

Read More

Editor's Note With COVID-19 rates rising again, and winter cold and flu season around the corner, it is time for healthcare personnel to get a COVID-19 booster shot to help protect against illness–and recommend patients to do the same. In a September 2023 TIME Magazine article, doctors weigh in on…

Read More

Editor's Note The Food and Drug Administration (FDA), on September 11, approved the Moderna and Pfizer/BioNTech updated COVID-19 boosters that target the Omicron subvariant XBB.1.5, the September 11 Reuters reports. The boosters, which were approved for those 12 years and older and authorized for emergency use for children ages 6…

Read More

Editor's Note The COVID-19 hospital admission rate in the US rose some 16% to more than 17,400 for the week ending August 26, and deaths increased by nearly 18% from the prior week, the September 7 New York Times reports. This marks the seventh consecutive week of increases. The Omicron…

Read More